This Soleno Therapeutics Insider Reduced Their Stake By 92%

From what we can see, insiders were net sellers in Soleno Therapeutics, Inc.'s (NASDAQ:SLNO ) during the past 12 months. That is, insiders sold the stock in greater numbers than they purchased it.

Although we don't think shareholders should simply follow insider transactions, we would consider it foolish to ignore insider transactions altogether.

See our latest analysis for Soleno Therapeutics

The Last 12 Months Of Insider Transactions At Soleno Therapeutics

In the last twelve months, the biggest single sale by an insider was when the insider, Jack Schuler, sold US$474k worth of shares at a price of US$1.52 per share. That means that an insider was selling shares at slightly below the current price (US$21.93). We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. However, while insider selling is sometimes discouraging, it's only a weak signal. This single sale was 92% of Jack Schuler's stake. Jack Schuler was the only individual insider to sell shares in the last twelve months.

You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

I will like Soleno Therapeutics better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Does Soleno Therapeutics Boast High Insider Ownership?

For a common shareholder, it is worth checking how many shares are held by company insiders. We usually like to see fairly high levels of insider ownership. Our data indicates that Soleno Therapeutics insiders own about US$6.9m worth of shares (which is 1.1% of the company). We do generally prefer see higher levels of insider ownership.

So What Do The Soleno Therapeutics Insider Transactions Indicate?

It doesn't really mean much that no insider has traded Soleno Therapeutics shares in the last quarter. Our analysis of Soleno Therapeutics insider transactions leaves us unenthusiastic. And usually insiders own more stock in the company, according to our data. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Soleno Therapeutics. At Simply Wall St, we found 3 warning signs for Soleno Therapeutics that deserve your attention before buying any shares.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.